CURE’s rare cancers page is a go-to resource for oncology news and updates in the world of rare cancers Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in rare cancers.
Patients with neuroendocrine tumors have more treatment options than ever before.
January 20th 2023, 2:00pm
Lytgobi was approved for pretreated cholangiocarcinoma in September, and updated study findings support the drug’s continued approval.
December 15th 2022, 4:00pm
When Sean Korbitz was a 20-year-old college student, his life trajectory changed with a rare cancer diagnosis, resulting in the removal of 40 tumors; fifteen years later, a new drug made him feel like a “medical miracle.”
December 14th 2022, 9:00pm
From eye removal to radiation damage, patients with uveal melanoma may face complications after treatment, although continued and new therapies may address these issues, an expert said.
December 12th 2022, 2:30pm
Tecentriq was approved by the FDA for adults and children aged two years and older with advanced alveolar soft part sarcoma, a disease typically diagnosed in approximately 80 patients per year in the U.S.
December 8th 2022, 4:00pm
After Marshall Morris was diagnosed with a rare cancer and given only six months to live, he created a charity that empowers people with terminal illness and provides them with counseling and support.
November 23rd 2022, 4:00pm
A woman whose husband was diagnosed with ocular melanoma at 28 years old opens up about her experiences navigating the cancer world and her search for a supportive community.
November 4th 2022, 7:00pm
A novel drug, MRT-2359, will be studied in a phase 1/2 trial for patients with MYC-driven cancers.
November 4th 2022, 3:00pm
From a childhood cancer survivor throwing out the first pitch at Game 4 of the World Series to former WWE champion and actor Dwayne “The Rock” Johnson recording a message for a child with brain cancer, here’s what’s happening in the cancer space this week.
October 26th 2022, 1:00pm
Advocacy groups helped one patient with ocular melanoma — and many others — learn more about their disease and treatment, as well as a place to connect about their experiences.
October 24th 2022, 9:00pm
Vaginal cancer is amongst the rarest of gynecologic cancer, it is important those patients with a rare cancer advocate for themselves and find doctors who are experts in treating it.
Biomarker Testing Remains Crucial for Young Patients With Lung Cancer
How Cancer Care Teams Can Help With the Cessation of Smoking
The OVATION 3 Study Initiates First Trial Site for Ovarian Cancer
Celebrating Nurses Week: The Heart and Soul of Our Cancer Community